Alessandra Bolino

Milan, 20132, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.

PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 24, 2025

Regulation of Schwann Cell-Axon Interactions in Nerve Development: The Role of Slit2 in Axonal Sorting.

Regulation of Schwann Cell-Axon Interactions in Nerve Development: The Role of Slit2 in Axonal Sorting.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: February 27, 2025

Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13.

Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13.

Journal: European journal of neurology
Published: October 28, 2024

Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD.

Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD.

Journal: Brain : a journal of neurology
Published: June 08, 2024

Correction: Molecular mechanisms and therapeutic strategies for neuromuscular diseases.

Correction: Molecular mechanisms and therapeutic strategies for neuromuscular diseases.

Journal: Cellular and molecular life sciences : CMLS
Published: June 03, 2024

Niacin ameliorates Charcot-Marie-Tooth 4B1 neuropathy without interfering with nerve regeneration.

Niacin ameliorates Charcot-Marie-Tooth 4B1 neuropathy without interfering with nerve regeneration.

Journal: Brain communications
Published: March 07, 2024

Molecular mechanisms and therapeutic strategies for neuromuscular diseases.

Molecular mechanisms and therapeutic strategies for neuromuscular diseases.

Journal: Cellular and molecular life sciences : CMLS
Published: January 02, 2024

Recent advances in the treatment of Charcot-Marie-Tooth neuropathies.

Recent advances in the treatment of Charcot-Marie-Tooth neuropathies.

Journal: Journal of the peripheral nervous system : JPNS
Published: December 28, 2022

Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy.

Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy.

Journal: European journal of neurology
Published: October 04, 2022

Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.

Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.

Journal: Molecular therapy. Methods & clinical development
Published: December 27, 2021

Myelin Biology.

Myelin Biology.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 28, 2021

Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy.

Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 03, 2021
Showing 1-12 of 32

Last Updated: 09/26/2026